- Report
- May 2024
- 99 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- October 2023
- 95 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- August 2023
- 105 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- June 2023
- 77 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- June 2025
- 152 Pages
China
From €4447EUR$4,995USD£3,885GBP
- Report
- March 2023
- 132 Pages
Global
From €846EUR$950USD£739GBP
- Report
- March 2023
- 132 Pages
Global
From €846EUR$950USD£739GBP
- Report
- November 2021
- 545 Pages
Global
From €3561EUR$4,000USD£3,111GBP
- Report
- November 2021
- 1184 Pages
Global
From €5341EUR$6,000USD£4,667GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more